Mark W. Frohlich
- Immunology top 0.5%
- Immunotherapy and Immune Responses 18
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 21
- CAR-T cell therapy research 14
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research 25
- Cancer Research top 2%
-
- Radiopharmaceutical Chemistry and Applications 6
-
- Chronic Lymphocytic Leukemia Research 11
-
- Multiple Myeloma Research and Treatments 3
-
- Seed Germination and Physiology 3
- Co-authors
- Eric J. SmallPaul F. SchellhammerCelestia S. HiganoPhilip W. KantoffRobert B. SimsYi XuDavid F. PensonAnna C. Ferrari
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (21 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mark W. Frohlich
58 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 3.4k
- Oncology 3.6k
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 744
- Radiology, Nuclear Medicine and Imaging 878
Countries citing papers authored by Mark W. Frohlich
This map shows the geographic impact of Mark W. Frohlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Frohlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Frohlich more than expected).
Fields of papers citing papers by Mark W. Frohlich
This network shows the impact of papers produced by Mark W. Frohlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Frohlich. The network helps show where Mark W. Frohlich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark W. Frohlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 101 | |
| 2 | 2014 | 163 | |
| 3 | 2014 | 24 | |
| 4 | 2013 | 14 | |
| 5 | 2013 | 179 | |
| 6 | 2012 | 203 | |
| 7 | 2012 | 20 | |
| 8 | 2012 | 7 | |
| 9 | Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancerbreakdown → | 2010 | 4077 |
| 10 | 2009 | 62 | |
| 11 | 2007 | 35 | |
| 12 | 2005 | 31 | |
| 13 | 2005 | 1 | |
| 14 | 2005 | 1 | |
| 15 | 2004 | 4 | |
| 16 | 1998 | 11 | |
| 17 | The effect of sex steroid hormones on serum leptin levels | 1997 | 1 |
| 18 | 1994 | 6 | |
| 19 | 1992 | 68 | |
| 20 | 1990 | 27 |
About Mark W. Frohlich
Mark W. Frohlich is a scholar working on Oncology, Immunology and Genetics, having authored 60 papers that have together received 6.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Seed Germination and Physiology (3 papers). The work is most often cited by research in Immunology (3.4k citations), Oncology (3.6k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Mark W. Frohlich has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Eric J. Small, Paul F. Schellhammer, Celestia S. Higano, Philip W. Kantoff, Robert B. Sims, Yi Xu, David F. Penson, Anna C. Ferrari, Neal D. Shore and Robert Dreicer. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.